Key result
Injection of CBD-VEGF preserved cardiac function, reduced scar size, and increased capillary density in rats with acute myocardial infarction compared to native VEGF.
Why the study?
Does CBD-VEGF improve cardiac function and reduce scar size in rats with acute myocardial infarction compared to native VEGF?
Does CBD-VEGF improve cardiac function and reduce scar size in rats with acute myocardial infarction compared to native VEGF?
Answers are grounded in this paper and cite their sources.
A collagen-targeted VEGF fusion protein improves cardiac function, reduces scar size, and increases angiogenesis in a rat model of acute myocardial infarction compared to native VEGF.
BACKGROUND: Vascular endothelial growth factor (VEGF) is an important active protein for the induction of angiogenesis and improvement in cardiac function after myocardial ischemia; however, the lack of a delivery system targeted to the injured myocardium reduces the local therapeutic efficacy of VEGF and increases its possible adverse effects. METHODS AND RESULTS: We produced a fusion protein (CBD-VEGF) consisting of VEGF and a collagen-binding domain (CBD). The fusion protein specifically bound to type I collagen in vitro. In addition, CBD-VEGF promoted human umbilical vein endothelial cell proliferation after binding to collagen, which indicates that it retained both growth factor activity and collagen-binding ability. When implanted subcutaneously in rats, collagen membranes loaded with CBD-VEGF were significantly vascularized. After it was injected into rats with acute myocardial infarction, CBD-VEGF was largely retained in the cardiac extracellular matrix, in which collagen I was rich. Four weeks after VEGF or CBD-VEGF was injected into the infarct border zone, cardiac function detected by echocardiography and hemodynamics was preserved in the CBD-VEGF group. Administration of CBD-VEGF also induced reduction of scar size, whereas native VEGF did not have these effects. In addition, a significant increase in the number of capillary vessels in infarcted hearts was found in the CBD-VEGF group. CONCLUSIONS: The injection of CBD-VEGF improved cardiac function in rats with induced acute myocardial infarction. This could potentially provide a new treatment option for myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2009) studied Acute myocardial infarction. CBD-VEGF vs. Native VEGF was evaluated on Cardiac function, scar size, and capillary vessel number. Injection of CBD-VEGF preserved cardiac function, reduced scar size, and increased capillary density in rats with acute myocardial infarction compared to native VEGF.
Synapse has enriched 10 related papers. Consider them for comparative context: